दवाओं की अंतःक्रिया
Upadacitinib + Vedolizumab
गंभीरता: गंभीर
Upadacitinib and Vedolizumab: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Using a JAK inhibitor with another biologic immunosuppressant increases the risk of serious infection. Vedolizumab acts mainly in the gut, so systemic effects are smaller, but combination data are limited.
इस इंटरैक्शन का सरल भाषा में अर्थ
Upadacitinib and Vedolizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Upadacitinib belongs to Musculoskeletal; Vedolizumab belongs to Gastrointestinal Tract.
ऐसा क्यों होता है
Additive immunosuppression via gut-selective integrin blockade and JAK inhibition.
क्या करें
Avoid routine concurrent use; the upadacitinib label advises against combination with biologic immunosuppressants. If combined, monitor closely for infection.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Upadacitinib और Vedolizumab की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Vedolizumab के अन्य इंटरैक्शन
Upadacitinib के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Upadacitinib with Vedolizumab?
MediHelp rates the interaction as major. Upadacitinib and Vedolizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Using a JAK inhibitor with another biologic immunosuppressant increases the risk of serious infection. Vedolizumab acts mainly in the gut, so systemic effects are smaller, but combination data are limited.
How serious is the interaction between Upadacitinib and Vedolizumab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine concurrent use; the upadacitinib label advises against combination with biologic immunosuppressants. If combined, monitor closely for infection.
What other medicines interact with Vedolizumab?
MediHelp also lists interactions of Vedolizumab with, for example, Natalizumab, Baricitinib, Certolizumab pegol. The full list is on the Vedolizumab page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
